Literature DB >> 7872763

In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.

C P Doit1, S P Bonacorsi, A J Fremaux, G Sissia, R Cohen, P L Geslin, E H Bingen.   

Abstract

We evaluated the in vitro killing activities of ceftriaxone, imipenem, vancomycin, gentamicin, fosfomycin, and rifampin, alone and in combination, against 26 Streptococcus pneumoniae strains (penicillin G MICs, > 0.125 to 2 micrograms/ml) isolated from the cerebrospinal fluid of children with meningitis. The antibiotics were tested at clinically achievable concentrations in cerebrospinal fluid. After 5 h of incubation, imipenem was the most effective drug. None of the combinations had synergistic activity. Killing by beta-lactam antibiotics or vancomycin was enhanced by the addition of gentamicin, reduced by the addition of rifampin, and unaffected by the addition of fosfomycin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7872763      PMCID: PMC188258          DOI: 10.1128/AAC.38.11.2655

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Effect of antibiotics carry-over on bacterial counting by 'spiral plating'.

Authors:  E Yourassowsky; M P Van der Linden; F Crokaert; Y Glupczynski
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

2.  The in-vitro activity of combinations of penicillin and gentamicin against penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.

Authors:  J Haynes; P M Hawkey; E W Williams
Journal:  J Antimicrob Chemother       Date:  1986-09       Impact factor: 5.790

3.  Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  J Modai; D Vittecoq; J M Decazes; A Meulemans
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790

4.  [Treatment of neurosurgical bacterial meningitis using the combination of ceftriaxone-fosfomycin].

Authors:  J P Stahl; J Croize; A Baud; J P Bru; P de Rougemont; P Le Noc; M Micoud
Journal:  Pathol Biol (Paris)       Date:  1986-05

5.  Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.

Authors:  R Latif; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

6.  Relatively penicillin-resistant pneumococcal infections in pediatric patients.

Authors:  M A Jackson; S Shelton; J D Nelson; G H McCracken
Journal:  Pediatr Infect Dis       Date:  1984 Mar-Apr

7.  Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.

Authors:  J Liñares; J L Perez; J Garau; L Murgui; R Martín
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

8.  Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.

Authors:  G H McCracken; Y Sakata
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

9.  Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.

Authors:  I R Friedland; M Paris; S Shelton; G H McCracken
Journal:  J Antimicrob Chemother       Date:  1994-08       Impact factor: 5.790

10.  Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.

Authors:  J M Decazes; J D Ernst; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

View more
  17 in total

1.  Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors:  F Fitoussi; C Doit; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 2.  Bacterial meningitis in children.

Authors:  M C Thirumoorthi
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

3.  Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin.

Authors:  C Doit; C Loukil; F Fitoussi; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.

Authors:  F Fitoussi; C Doit; K Benali; S Bonacorsi; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

5.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Authors:  K Tateda; K Takashima; H Miyazaki; T Matsumoto; T Hatori; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

6.  Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  C Darras-Joly; J P Bédos; C Sauve; P Moine; E Vallée; C Carbon; E Azoulay-Dupuis
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.

Authors:  Y S Kim; Q Liu; L L Chow; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 8.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

9.  Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children.

Authors:  Catherine Doit; Chawki Loukil; Pierre Geslin; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis.

Authors:  Shin-Woo Kim; Joung Hwa Jin; Soo Jung Kang; Sook-In Jung; Yeon-Sook Kim; Choon-Kwan Kim; Hyuck Lee; Won Sup Oh; Sungmin Kim; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.